On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters New Licensing Agreement, Strengthens Business Model

  • Lexaria continues to create a strong, revenue-generating business model to support its growing patent portfolio
  • The company out-licenses disruptive delivery technology, giving licensees access to existing patents
  • Lexaria entered into a new beverage license agreement with a California-based cannabis firm
  • The company recently announced four new appointments to its scientific advisory board

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a drug-delivery platform innovator with existing cannabinoid licensing agreements in Canada and the United States, as well as internationally. By out-licensing disruptive delivery technology DehydraTECH, the company has created a strong, revenue-generating business model and a growing patent portfolio.

At the end of 2018, LXRP held 10 granted patents, with 53 patent applications filed and pending in more than 40 countries around the world. The company is unique in that it is the only global company with patents issued for the oral delivery of all cannabinoids. DehydraTECH has patents for cannabidiol (CBD), all other non-psychoactive cannabinoids, other psychoactive compounds, fat-soluble vitamins, NSAIDs (nonsteroidal anti-inflammatory drugs such as ibuprofen), nicotine and other molecules.

Lexaria out-licenses DehydraTECH, giving licensees access to its many existing patents. These patents include combinations of ready-to-drink beverages, wine, coffee, tea, sports drinks, supplements and more. Third-party partners and start-up businesses are currently paying royalties for cannabinoid licensing agreements, and a Fortune 100 company has licensed Lexaria’s technology for oral nicotine delivery in the U.S.

The company continues to grow additional revenue streams. On April 24, 2019, Lexaria announced (http://nnw.fm/6iWI3) its entry into a new beverage license agreement with a private California-based cannabis company. The financial terms of the definitive five-year agreement were not disclosed. LXRP’s patented DehydraTECH technology will be used by the private company in producing and selling cannabis-based beverages in California and Nevada. Last year, Lexaria announced that a Canadian company had licensed its technology to produce cannabis beverages in Canada.

DehydraTECH is unique in that it promotes healthier ingestion methods. The technology improves taste, rapidity and delivery of bioactive compounds while removing odor. This allows cannabinoids and other bioactive compounds to be delivered in high-quality food products and beverages without the need for additional sugars. It also provides a safer means of ingestion than the more traditional method of smoking.

In addition, Lexaria continues to strengthen its scientific research and product development team and has appointed four new members to its scientific advisory board. “Lexaria is building towards becoming one of the world’s leaders in drug-delivery technology, and our most recent advisors can assist in achieving that goal,” Lexaria CEO Chris Bunka stated in a news release.

To learn more about the background, interests and expertise that each new appointment brings to the company, read the announcement at http://nnw.fm/fx5wW. These new board members will be providing critical scientific guidance to the company’s ongoing and future research and development programs.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://nnw.fm/LXRP

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.networknewswire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office


Select A Month

NetworkNewsWire Currently Accepts



Bitcoin Cash

Bitcoin Cash

Doge Coin






USD Coin

USD Coin

Contact us: 212.418.1217